(S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
97%
- Product Code: 71490
CAS:
14769-73-4
| Molecular Weight: | 204.29 g./mol | Molecular Formula: | C₁₁H₁₂N₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 230-233°C | Boiling Point: | 344.4°C |
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. It plays a significant role in the development of drugs targeting neurological disorders, particularly those related to dopamine regulation. Its structural framework is often incorporated into molecules designed to act as dopamine receptor agonists, which are used in the treatment of conditions like Parkinson's disease and restless legs syndrome. Additionally, its unique imidazothiazole moiety contributes to the enhancement of pharmacokinetic properties, such as improved bioavailability and metabolic stability, in drug candidates. Researchers also explore its potential in creating novel compounds with anti-inflammatory and analgesic properties, making it a versatile building block in medicinal chemistry.
Product Specification:
| Test | Specification |
|---|---|
| Purity | 97-100 |
| MELTING POINT | 227-236 |
| APPEARANCE | White to off-white solid |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿1,820.00 |
+
-
|
| 1.000 | 10-20 days | ฿4,580.00 |
+
-
|
| 5.000 | 10-20 days | ฿13,800.00 |
+
-
|
(S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole
This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. It plays a significant role in the development of drugs targeting neurological disorders, particularly those related to dopamine regulation. Its structural framework is often incorporated into molecules designed to act as dopamine receptor agonists, which are used in the treatment of conditions like Parkinson's disease and restless legs syndrome. Additionally, its unique imidazothiazole moiety contributes to the enhancement of pharmacokinetic properties, such as improved bioavailability and metabolic stability, in drug candidates. Researchers also explore its potential in creating novel compounds with anti-inflammatory and analgesic properties, making it a versatile building block in medicinal chemistry.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :